COMMUNIQUÉS West-GlobeNewswire

Altimmune to Announce Second Quarter 2018 Financial Results on August 15
07/08/2018
GAITHERSBURG, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the quarter and year ended [...]
CLS Holdings USA Closes $3 Million Investment from Navy Capital
07/08/2018
Growth Equity Capital from Leading Cannabis Focused Institution LAS VEGAS, Aug. 07, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences [...]
TACTI-mel Patient Recruitment Complete and Operational Update
07/08/2018
Patient recruitment completed for Part B of ongoing TACTI-mel Phase I clinical trial Progress on Immutep’s TACTI-002 and AIPAC GSK nominates ulcerative colitis as its lead indication for IMP731 ( GSK2831781 ) Novartis [...]
iCAD to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Tuesday, August 14th
07/08/2018
NASHUA, N.H., Aug. 07, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of [...]
Novo Nordisk A/S - Share repurchase programme
07/08/2018
Bagsværd, Denmark, 7 August 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update
07/08/2018
Second quarter 2018 TYMLOS sales increase to $22.6 million, a 56% increase over the first quarter of 2018 TYMLOS’ share in the U.S. anabolic osteoporosis market increased to an average of 19% in the second quarter from [...]
Albireo Reports Second Quarter 2018 Financial Results
07/08/2018
A4250 Phase 3 trial in PFIC underway A4250 granted rare pediatric disease designation, eligible to apply for priority review voucher Management to host conference call and webcast today at 8:30 a.m. EDT BOSTON, Aug. 07 [...]
Marinus Pharmaceuticals to Present at Wedbush/PacGrow Healthcare Conference
07/08/2018
RADNOR, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
07/08/2018
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that target enrollment in the ULTIMATE I and II Phase 3 trials has been achieved. ULTIMATE I and II are two independent [...]
Ziopharm Oncology Announces Changes to its Board of Directors
07/08/2018
Scott Tarriff, CEO of Eagle Pharmaceuticals, Elected Lead Director Sir Murray Brennan, M.D., former U.S. Sen. Wyche Fowler to Step Down Paratek Pharmaceuticals CFO Doug Pag á n and Scholar Rock COO Elan Ezickson [...]
Avadel Pharmaceuticals Reports Second Quarter 2018 Financial Results
07/08/2018
DUBLIN, Ireland, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, [...]
Spark Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Progress
07/08/2018
As of July 13, 2018, preliminary Phase 1/2 data for investigational SPK-8011 for hemophilia A show: A 97-percent reduction in annualized bleeding rate (ABR) and 97-percent reduction in annualized infusion rate (AIR) [...]
BioCorRx Provides Update on BICX102
07/08/2018
ANAHEIM, CA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced a general [...]
Avalon GloboCare Forms Strategic Partnership with Weill Cornell Medical College to Co-develop Technologies and Bio-production of CAR-T Therapy
07/08/2018
FREEHOLD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has formed a strategic [...]
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
07/08/2018
Solid Performance from New Product Launches Vabomere TM Granted NTAP Status by CMS Strengthened Financial Position Supports Continued Growth Completed Expansion and Cross-Training of Experienced Anti-infective Sales [...]
Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors
07/08/2018
NORTHVALE, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today the appointment of Aqeel A. Fatmi, Ph.D. to its Board of Directors. Dr. Fatmi [...]
Anavex Life Sciences to Announce Fiscal Third Quarter 2018 Financial Results on Thursday, August 9, 2018
07/08/2018
Conference Call and Webcast To be Held Thursday, August 9, 2018 at 4:30pm Eastern time NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp., (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
07/08/2018
A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modification CALGARY, Alberta,, Aug. 07, 2018 (GLOBE NEWSWIRE) -- [...]
Merus to Present at the 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
UTRECHT, The Netherlands, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

Pages